Screening for early disease has been available for many years, but there is still no national screening programme established in the United Kingdom.
(PMID: 23728749) In the case of prostate cancer screening, two systematic reviews have concluded that screening should not be carried out.
In general, this recommendation has been accepted in the United Kingdom.
(PMID: 11495383) Increased usage of Prosdex leads to more informed decision making, the key aim of the UK Prostate Cancer Risk Management Programme.
(PMID: 20507844).
